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Abstract 
Background: To report an uncommon case of hand, foot and mouth disease, (HFMD) in an immunocompetent 
adult; a highly infectious disease, characterized by the appearance of vesicles on the mouth, hands and feet, associ‑
ated with coxsackieviruses and enteroviruses; including a literature review.
Case report: A 23 year Caucasian male with no medical or surgical history, no allergies, was not taking any medica‑
tion and smoked ten cigarettes a day, suffering from discomfort in the oral cavity; itching, burning and pain when 
swallowing associated with small erythematous lesions located on the hard palate, and small ulcers in tonsillar pillars 
and right buccal mucosa. Mild fever of 37.8 °C and general malaise. The patient reported he had had contact with a 
child diagnosed with HFMD. From his background and symptoms, the patient was diagnosed with HFMD. Following 
symptomatic treatment, the symptoms remitted in 7 days.
Methods: A literature review in MEDLINE (PubMed). The inclusion criteria were for studies on humans over the last 
5 years, using the keywords HFMD.
Results: We found 925 articles, which were subsequently reduced to 52 documents after applying the inclusion 
criteria. Maculopapular lesions were found on hands and feet.
Conclusions: Dentists may have a key role diagnosing the disease. A surveillance system to predict future outbreaks, 
encourage early diagnosis, put appropriate public health measures in place and research vaccine development is 
vitally important in order to control the disease.
Keywords: HFMD, Immunocompetent, Adult, Dentistry, Oral health, Case report
© 2016 Omaña‑Cepeda et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
In 1958, Robinson et al. first described the outbreak of 
a highly infectious disease in Toronto in 1957, char-
acterized by the appearance of vesicles on the mouth, 
hands and feet [1]. It was isolated coxsackievirus (CV) 
A16. Hand foot and mouth disease (HFMD) rarely 
appears as an epidemic infectious disease. However it 
is the most common infectious disease in China, with 
an incidence rate of around 500,000–1,000,000 cases 
per year [2]. It is associated with climate changes, usu-
ally occurring in spring and summer [3]. It occurs most 
often in children between 0 and 5 years old [4, 5] and 
immunocompromised adults [6], due to their high sen-
sitivity to the enterovirus 71 (EV71) and CVA16 [7]. 
However, it can also occur in immunocompetent adults 
[5, 6]. Some of the major causative agents are EV71, 
CVA16 [8], and it was recently described, CVA6 and 
CVA10 [9–11].
The main routes of transmission are person-to-person 
(through oral-pharyngeal secretions or by direct vesicle 
contact), via contaminated water (fecal-oral route) [12], 
and via contaminated objects.
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The incubation period is short, ranging from 2 to 7 
days. It shows non-specific symptoms, but there may be 
mild fever and catarrhal manifestations. The initial viral 
implantation is in the oral cavity and ileum, spreading 
to the regional lymph nodes within 24 h. Viremia occurs 
after 72  h, followed by secondary infection and viral 
seeding in areas such as the oral mucosa, hands and feet. 
On the seventh day, there is an increase in antibody levels 
and the disease begins to disappear [13].
Oral lesions are the first clinical signs of the disease, 
and are sometimes the only sign, because they appear 
even before the lesions on the extremities [12]. Mani-
festations of the disease on the skin consist of multiple 
lesions on the hands and feet, and occur concurrently or 
shortly after the oral lesions. Systemic features are sum-
marized in the Table 1 [13, 14].
A study in Japan suggests the possibility that the HFMD 
could also cause opsoclonus-myoclonus (jerky eye move-
ments in all directions) as a possible viral or autoimmune 
response [15], other studies reports cases of retinopathy 
and vision loss in this entity [16].
The diagnosis is by observing the clinical signs of the 
disease, such as fever and the characteristic lesions on the 
hands, feet and mouth. Confirmation of diagnosis is car-
ried out by isolating the virus responsible for the disease, 
or by identifying virus-neutralizing antibodies in patient 
serum [5].
There are varieties of studies investigating possible 
treatments for HFMD. One such study considers using 
intravenous immunoglobulin (IVIG) as therapy against 
HFMD [17, 18]. However, because the disease is self-
limiting in nature and due to the lack of a virus-specific 
therapy, the present treatment is symptomatic. Non-spe-
cific rinses with anesthetic substances can be employed 
to relieve oral discomfort. In addition, ensure that the 
patient gets plenty of fluids and avoids spicy and acidic 
foods, and foods that require a lot of chewing.
In most cases, the prognosis is good moving toward 
spontaneous healing within 7–10  days without seque-
lae, scabs or scars. However, there have been reports 
of onychomadesis associated with the disease [19–21], 
in addition to neurological disorders such as menin-
gitis (EV-4) [22], Guillain–Barre syndrome, menin-
goencephalitis, as well as paralytic polio, myoclonus 
and somnolence, mainly caused by the sub genotype 
C4aEV71 [23], in children under 5  years (the main risk 
group in the population) [24]. It has been shown that 
most of these patients have low levels of vitamin A, 
associated with reduced immunity, and they are there-
fore more susceptible to a more severe manifestation of 
the disease [25]. Note also that delays in access to health 
services lead to an increased likelihood of a more severe 
form of the disease [4, 26, 27].
The aim of this article is to present a case of HFMD 
in an immunocompetent adult, alongside a literature 
review. The article also aims to identify the etiologic 
agents and publicize transmissible factors in order to cor-
rectly diagnose patients, and thus to establish an effective 
treatment plan both individually and collectively.
Case report
In May 2014, coinciding with the springtime, a 23  year 
Caucasian male went to the Odontology Hospital of the 
University of Barcelona. He had no familiar, medical or 
surgical history, no allergies, not taking any medication 
and smoked ten cigarettes a day. He was suffering from 
discomfort in the oral cavity: itching, burning and pain 
when swallowing associated with small erythematous 
lesions located on the hard palate, and small ulcers in 
tonsillar pillars and right buccal mucosa. The patient had 
a mild fever of 37.8 °C and general malaise. The examina-
tion also found maculopapular lesions on the hands and 
feet, some of which were in the form of blisters (Figs. 1, 2 
and 3). Upon questioning the patient, he stated that a few 
days earlier (7–10  days), he had been in contact with a 
2-year-old girl who was diagnosed with HFMD, and that 
other members of the child’s family had suffered the same 
symptoms.  
From his background and symptoms, the patient was 
diagnosed with HFMD and symptomatic treatment was 
begun with analgesics (650 mg paracetamol three times 
a day), hygiene, and a diet that would not irritate the 
symptoms further. The patient controlled the symp-
toms for 7 days until the disease subsided. An analyti-
cal control was requested in which no evidence of any 
significant alteration was shown. We conducted a fol-
low-up visit after 15 days and did not find any residual 
lesions.
Table 1 Systemic manifestations oh HFMD [14, 15]
Systemic features of HFMD Systemic features in severe occurrences of HFMD
Anorexia, fever, low pollution, sore throat, runny nose, abdominal  
pain, and sometimes myalgia, lymphadenopathy, diarrhea, nausea  
and vomiting
Skin rashes, fever ≥38 °C, neurological symptoms, respiratory symptoms 
such as tachypnea or bradypnea, pulmonary edema, cardiovascular 
symptoms such as tachycardia and hypertension, bleeding, pulmonary 
consolidation, hyperglycemia, elevated leukocyte and high levels of lactic 
acid
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Methods and results
A literature review was performed via an automated 
search for information on the database: MEDLINE (Pub-
Med) to identify and summarize all relevant publications 
on HFMD. The search strategy was based on the terms 
HFMD. The inclusion criteria was for studies on humans, 
over the last 5  years that identify the etiologic agents, 
disclose communicable factors, correctly diagnose the 
patients, and establish an effective treatment plan both 
individually and collectively. We assessed the eligibil-
ity of articles from the titles and abstracts, and extracted 
the information related to our target subject. We also 
included an article by Delgado et al. [13], as well as two 
older articles for their importance to the history of the 
disease: Robinson et al. [1], and Alsop et al. [28].
We found 925 publications in PubMed with the key-
words listed, of which 627 were based on humans and 
published in the last 5  years, which was reduced to 92, 
when we limit the search to studies in adults. We selected 
49 papers that met the objectives of our research and the 
inclusion criteria. We included 26 of the 52 total papers 
as a systematic review, based in the number of cases 
presented and type of studies, and addressing the issues 
developed: the relationship between climate changes and 
HFMD, causes, complications and epidemiological stud-
ies on severe forms of HFMD, the remaining papers was 
included for the discussion and development of theme 
(Fig. 4).
Discussion
HFMD is a syndrome caused by intestinal viruses from 
the Picornaviridae family, and is mainly characterized by 
the appearance of vesicular lesions on the mouth, hands 
and feet. It is more common in children under 10 and in 
vulnerable adults. Nonetheless, it can also occur in young 
immunocompetent adults [6, 9–11, 15], as in the case 
reported.
For this review, we will build on the most relevant 
items and features that in relation with the HFMD are 
described in the selected papers.
Climate
Recent studies suggest a strong association between 
HFMD and climate changes, as the incidence of the dis-
ease increases in the springtime, when our case occurred. 
However, the exact reason for this association has not 
been studied yet. Different studies show contradictions in 
temperatures, while Wang et al. [4] provides the greatest 
incidence range between 21.1 and 26.6 °C. A study by Hii 
et al. [29] cites data above 32 °C and in periods where the 
temperature difference between the minimum and the 
maximum is greater than 7 °C. Neither is rainfall a clear 
risk factor, since according to Wang et  al. [4] there are 
Fig. 1 Lesions on the hard palate, soft and tonsillar pillars
Fig. 2 Lesions on the palm and fingers
Fig. 3 Lesions on the foot
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more cases with high rainfall, while for others [29] there 
is a low incidence rate 0.5  % for rainfall above 75  mm 
(Table  2). The biological relationship between climate 
indicators and EV activity is quite complicated and differ-
ent reports on the subject do not reveal the same results, 
so it deserves to be investigated in future studies to get 
better information on this relationship [2, 29].
Sex
As for sex, recent studies suggest a higher prevalence in 
males than in females [4, 26, 30]. In contrast, no signifi-
cant differences have been demonstrated in the genre and 
viral load between mild and severe cases [23].
Etiology
The main causative agents are CVA16 and EV71 [17]. 
Moreover, outbreaks caused by CVA4, CVA5, CVA6, 
CVA9, CVA10, CVA12, CVB1, CVB3 and CVB5 have 
been observed [3, 9–11, 31–34]. Links have also been 
found between EV-4, HFMD and meningitis [22]. There 
is a low incidence in the cases documented in Europe, 
with a greater predominance of CVA16 infections. In 
contrast, in Asian countries such as China, the actual 
incidence of this disease is much higher and it has been 
shown that there is a large predominance of the EV71 
virus in these countries, in particularly genotype C4 
where the cases appear to be more severe (Table 3).
Diagnosis and differential diagnosis
Diagnosing the disease is relatively easy by looking at the 
clinical features of the disease.
In oral mucosa, an enanthem appears after 1–2  days 
and on the soft palate, inner cheeks, gums, gingival–
labial groove and tongue. In our case study, the lesions 
appeared in less common areas such as the hard palate, 
tonsillar pillars and the right buccal mucosa. It consists of 
5–10 small vesicles, which are very painful, covered with 
a yellowish pseudomembrane and surrounded by an ery-
thematous halo. They measure between 3 and 7  mm in 
diameter (typically 5 mm). The enanthem breaks, form-
ing small ulcers, as the oral epithelium is thin, which 
allows the vesicles to break easily during movements 
925 Journal articles obtained 
via a PubMed keyword 
search
627 articles on humans 
published in the last 5 years 
2 relevant articles preceding 
the date search
1 relevant article not 
obtained from PubMed
10 case reports
6 literature reviews
28 transverse retrospective observational studies
1 cross prospective observational study
3 retrospective cohort studies
1 case-control study
1 controlled prospective nonrandomized clinical trial
2 meta-analysis
92 in adults
49 relevant articles included 
in this review
26 articles included as a systematic review.
(Studies on the relationship between climate 
changes and HFMD, causes, complications, 
and epidemiological studies on severe forms of 
HFMD)
Fig. 4 Diagram of article selection
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associated with speech and chewing. These vesicles can 
hinder food consumption because the tongue may be 
swollen and painful [13] (Fig. 1).
Skin vesicles can vary in number from a few to 100. 
Characteristically, they appear on the sides and back 
of the fingers, around the nails, around the heel and on 
the palm of the hand and soles of the feet. Occasion-
ally they can appear on the knees and buttocks. Skin 
lesions, in our case, appeared on the sides and backs 
of the fingers and toes of our patient, and appeared in 
the locations described elsewhere. It measures approxi-
mately 3–7  mm in diameter. They are surrounded by 
an erythematous halo. The vesicle wall is thin and may 
be preceded by a maculopapular rash. They move into 
vesicular stage and then go on to develop scabs and 
ulcers [6, 13] (Figs. 2, 3).
Histopathological examination of skin vesicles revealed 
the presence of intraepithelial vesicles, within which 
there are fibrin, epithelial cells and reticular degenera-
tion balonica, neutrophils, mononuclear cells and eosino-
philic proteinaceous content [13].
In the differential diagnosis of lesions on the oral 
mucosa, the lesions that should be considered are pri-
mary herpetic gingivostomatitis, herpangina, erythema 
multiforme, aphthous stomatitis and chickenpox. It is 
very important to establish a correct diagnosis to avoid 
prescribing inappropriate drugs [17, 35].
Although it is not a serious disease, an early diagno-
sis is important to avoid epidemics on the pediatric 
population. There must be communication between 
the different branches of medicine and dentistry. The 
role of the dentist is important, as he/she is one of the 
professionals who must help with diagnosis when the 
patient seeks professional advice for painful oral lesions. 
Another diagnostic method studied recently by Yu et al. 
is the use of IgM ELISA in EV71 and CVA16 infections 
to correctly identify the virus causing the disease in 
patients [36].
Complications
Cases of HFMD associated with onychomadesis have 
been documented. This relates to the fact that viral rep-
lication could damage the nail matrix and produce tran-
sient nail dystrophy. Although several cases have been 
documented for patients infected with CVA10, further 
studies are needed to determine the causative agent of 
HFMD associated with onychomadesis [13]. It is not 
necessary to treat the nails in any way except by keeping 
the area clean and avoiding further injury. In all of the 
reported cases, the nail disorders resolved themselves 
spontaneously over the course of several weeks [21] 
(Table 4).
Complications have been cited on a neurological level, 
and early recognition of the children at risk is the key 
to reducing mortality and severe morbidity [7, 37, 38] 
(Table 3). It was therefore shown that administration of 
mannitol, methylprednisolone, IVIG and other support-
ive treatments may prevent the disease worsening in 
Table 2 Studies on the relationship between climate changes and HFMD
HFMD hand, foot and mouth disease
Study Results Conclusions
HanWang et al. Bei‑
jing, China 2011 [4]
Spring OR = 1.4–1.6
Other seasons OR ≤1.2
Increased risk of transmission:
 Temperature 21.1–26.6 °C
 High relative humidity
 Low wind speed
 High rainfall
 High population density
 Schools open
Strong relationship between climatic factors 
and the transmission of HFMD
Hii et al. Umeå, Swe‑
den 2011 [29]
 With each degree Celsius that the maximum temperature rises 
above 32 °C, the risk of disease incidence increases by 36 %
 Rainfall below 75 mm increases risk by 0.3 %. Above 75 mm, risk fell 
by 0.5 %
 Temperature differences of more than 7 °C between the minimum 
and maximum temperature increase the incidence rate by 41 %
The results suggest a strong association 
between HFMD and climate changes
Park et al. South 
Korea, 2010 [12]
 Having a non‑water closet toilet, changes in water quality, and 
contact with HFMD patients were associated with risk of HFMD 
(OR = 3.3, 2.8, 6.9, and 5.0, respectively)
 Visiting a hospital, changes in water quality, presence of a skin 
wound, eating out, and going shopping were significantly associ‑
ated with the risk of HFMD (OR = 9.0, 37.0, 11.0, 12.0, 37.0, and 
5.0, respectively)
The results suggest that seasonal variations, 
geographic localization, person to‑person 
contact and contaminated water could be 
the principal modes of transmission of HFMD
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severe cases, and improve the rate of successful recov-
ery in patients with nervous system complications [39] 
(Table 3).
Severe forms
It is worth noting the large number of reports on Asian 
patients with HFMD and severe neurological complica-
tions caused by EV71, which can rapidly progress to ful-
minant cardiorespiratory failure and death. All the above 
studies are consistent with the fact that EV71 is the virus 
most responsible for serious manifestations of HFMD, 
and children under 2–4 years are the main group at risk 
of such complications. However it has not yet been deter-
mined whether neutralizing antibody responses in the 
early stages of infection correlate with the clinical sever-
ity of the disease in patients with EV71 [40, 41] (Table 5).
In a meta-analysis by Li et al. [42], in mainland China 
and Taiwan, concluded that blood counts increased glu-
cose and leukocytes in severe forms of the disease, are a 
tool that can help physicians to anticipate the diagnosis 
and treatment of these patients efficiently.
Fang et al. in 2014 [43], in a meta-analysis of Risk fac-
tors of severe HFMD, concluded that Duration of fever 
≥3 days, body temperature ≥37.5 °C, lethargy, hypergly-
cemia, vomiting, increased neutrophil count, EV71 infec-
tion, and young age are risk factors for severe HFMD. A 
confirmed diagnosis at first visit to hospital can signifi-
cantly decrease the risk of severe HFMD.
Recently, cellular receptors have been identified, along 
with host factors that stimulate EV71. Several lines 
of research suggest that the scavenger receptor class 
B, member 2 (SCARB2) plays a crucial role in EV71 
Table 3 Studies related to the causes of HFMD
HFMD hand, foot and mouth disease
Study Results Conclusions
Zhu et al. Beijing, China 
2009 [27]
51 cases with HFMD
 25 CVA16 positive cases
 4 C4aEV71 positive cases
 7 Cases neither positive for EV71 nor CVA16
In 2007 in China there was a higher incidence of HFMD 
caused by CVA16
Osterback et al. Turku, 
Finland 2009 [31]
35 cases with HFMD
 34 CVA6 positive cases
CVA6 is emerging as the primary cause of the disease
Zhang et al. Pekín, 
Beijing 2009 [5]
70 cases with HFMD
 30 Positive for enterovirus initiation: 66.7 % positive 
for EV71
 At 4 days: 66.7 % positive for EV71
 At 5 days: 12.9 % positive for EV71
Samples must be collected within 4 days after the onset of 
the disease, because there is more likelihood of positive 
viral detection
Blomgvist et al. Helsinki, 
Finland 2010 [3]
317 cases with HFMD
212 positive cases of CVA6 and/or CVA10
Outbreak due to new genetic variants of the Coxsackie 
virus, CVA10 and CVA6
Rabenau et al. Frankfurt, 
Germany 2010 [52]
696 cases with HFMD
 88–73 % of children under 4 years are susceptible to 
infection
 30.6 % seropositive for both viruses
 43.5 % neutralizing antibodies (Ntab)
 25.9 % did not have antibodies
The seroprevalence study shows a common dissemination 
of CVA16 and EV71 in Germany, and a comparatively 
higher sensitivity in the younger population
Liu et al. Nanchang, 
China 2011 [14]
109 cases with HFMD
 90 % children under 8 years
 High prevalence of subgenotype C4
C4aEV71 genotype is now the more common infectious 
agent in China
Yang et al. Beijing, China 
2011 [32]
301 cases with HFMD
 Enterovirus (HEV) (88.4 %), EV71 (50.4 %), CVA16 
(38.3 %), CVA4 (1.1 %), CVA6 (1.1 %), CVA10 (1.1 %), 
CVA12 (2.6 %), CVB (5.3 %)
HFMD epidemics can persist for a long time in China, due 
to the different genetic variations in the composition 
of the virus, enteroviral characteristics of recombination 
and co‑infection, increased travel, migration and the lack 
of an effective vaccine
Yan et al. Shanghai, 
China 2011 [30]
3208 HFMD cases
EV71—86.5 %, CVA16—6.9 %, CVA16 + EV71—17.6 %
Children 1–4 years 76.9 %
M:F—65.3 %: 34.7 %
Subgenotype C4 of EV71 circulating
The subgenotype C4 of EV71 was the main causative 
agent of the epidemic in Shanghai. The group most 
affected were children under 4 years. There was a higher 
prevalence in boys than in girls. High incidence of mixed 
infections of EV71 and CVA16
Rabenau et al. Frankfurt, 
Germany 2010 [52]
696 cases with HFMD
 88–73 % of children under 4 years are susceptible to 
infection
 30.6 % seropositive for both viruses
 43.5 % neutralizing antibodies (Ntab)
 25.9 % did not have antibodies
The seroprevalence study shows a common dissemination 
of CVA16 and EV71 in Germany, and a comparatively 
higher sensitivity in the younger population
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infection and later development into severe forms of the 
disease [44].
Vaccine
The EV71 vaccine is also important for preventing infec-
tion. Recent studies show that both serotypes of human 
leukocyte antigen, HLA-A33 (class I) and HLA-DR17 
(class II), have significant associations with EV71 infec-
tion, suggesting that cellular immune response may play 
an important role in human immunity against EV71 
infection [45]. It was also found that the most severe 
cases of EV71, characterized by pulmonary edema, had 
lower cell specific antigen cytokines (Th1) and a lower 
lymphocyte proliferation response to the EV71 antigen in 
comparison with milder cases. This suggests that cellular 
immune response correlates with the clinical severity of 
HFMD. Namely, induction of cellular and humoral immu-
nity should be considered when developing vaccines and 
further analyzed in clinical trials [44]. In 2010, effective 
antiviral agents and vaccines against this virus was under 
Table 4 Studies related to the complications of HFMD
HFMD hand, foot and mouth disease, S sensitivity, E specificity, PPV positive predictive value, NPV negative predictive value
Study Results Conclusions
Ooi et al. Sarawak, Malasia 
2009 [7]
725 HFMD cases
 Risk factors: fever ≥3 days (1), fever ≥38.5 °C (2), lethargy history 
(3)
 ≥2 factors present in 65 % of children with pleocytosis in CSF, 
compared to 30 % without it
 2–3: S 28 %, E 89 %, PPV 79 %, NPV 50 %
 1: S 75 %, E 59 %, PPV 75 %, NPV 59 %
There are three risk factors to identify children 
with possible neurological disorders that 
are easily identifiable:
 Fever ≥3 days duration
 Fever ≥38.5 °C
 History of lethargy
Cho et al. Seoul, Korea 
2010 [23]
16 HFMD cases associated with: meningitis (10), Guillain–Barré 
syndrome (3), meningoencephalitis (2), poliomyelitis associated 
with acute flaccid paralysis (1) myoclonus (1)
11 positive cases for C4aEV71
Most neurological manifestations are caused 
by C4eEV71
Guimbao et al. Zaragoza, 
Spain 2010 [20]
27 Onychomadesis cases
24 had previously submitted HFMD
Virus CVB1 and 2
Strong association between HFMD and 
onychomadesis. Microbiological results 
inconclusive
Davia et al. Valencia, Spain 
2011 [19]
221 Onychomadesis cases associated with HFMD: 61 %
CVA10 present in 49 %
Other viruses: CVA5, 6, 16, B1 and B3, echovirus 3, 4, and 9, and 
EV71
The 2008 onychomadesis outbreak in Spain 
was associated with HFMD caused primarily 
by the CVA10 virus
Tian et al. China 2011 [38] 147 HFMD cases. Majority <3 years. 69.4 % males
Rashes and fever ≥38.5 °C 100 %
100 % CNS involvement (lethargy 84.4 %, myoclonus 51.7 %, 
drowsiness 23.1 %), tachypnea 76.2 %, bradypnea 14.3 %, hyper‑
tension 15.5 %, increased chest 51.7 %, consolidation of the 
thorax 29.9 %, hyperglycemia 86.4 %, high levels of lactic acid 
88.4 %, positive EV71 76.9 %
Treatment: mechanical ventilation for 61.2 ± 12.8 h (range 
40–96 h), mannitol, dexamethasone, gamma globulin, ribavirin, 
dopamine (58.5 %), dobutamine (51.0 %), amrinone (21.8 %)
2 % Died during hospitalization. Everyone else had a full recovery 
and were discharged after 14.2 ± 1.6 days (range, 12–17)
The central nervous system and cardiac 
system are involved in patients with severe 
HFMD. Fasting blood sugar and increased 
lactic acid levels in the majority of patients
Mechanical ventilation support and drug 
treatment are associated with good clinical 
outcome of these patients
Wei et al. Taiwan, China 
2011 [21]
130 HFMD cases by CVA6
 Perioral rash (22 %), rash on body and/or neck (30 %), general rash 
(5 %), hand‑foot‑mouth rash (51 %), peeling of palms and soles 
of the feet (37 %), onychomadesis (5 %)
Patients with CVA6 associated HFMD symp‑
toms of infection saw a broader spectrum 
of the destruction to the skin and deeper 
tissues, such as nail abnormalities and 
peeling
Chang et al. Taiwan. [45] 219 enterovirus 71 case subjects and 97 control children
 74 % (163 of 219 cases) were complicated cases, 57 % (125 of 
219 cases) are complicated cases with central nervous system 
involvement, and 17 % (38 of 219 cases) involved cardiopulmo‑
nary failure after central nervous system involvement
 Necrosis factor α promoter type II (‑308 A allele), HLA‑A33, and 
HLA‑DR17 were significantly associated with enterovirus 71 
susceptibility
 HLA‑A33 was the gene most significantly susceptible to entero‑
virus 71. HLA‑A2 was associated with the development of 
cardiopulmonary failure
HLA‑A33, which is a common phenotype in 
Asian populations but is rare in white popu‑
lations, was most significantly associated 
with enterovirus 71 infection, compared 
with the other candidate genes studied, 
whereas HLA‑A2 was significantly related to 
cardiopulmonary failure
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HFMD hand, foot and mouth disease
Table 5 Epidemiological studies on the more severe forms of HFMD
Study Results Conclusions
Liu et al. Shenzhen, 
China 2008 [37]
145 HFMD cases
124 mild cases 35 % +EV71
21 severe cases 67 % +EV71
Leukocytes and blood glucose levels of the most serious were signifi‑
cantly elevated. Age was less in severe cases (P < 0.05)
EV71 mainly contributes to severe HFMD
High fever, elevated white blood cell count, 
high blood glucose concentrations and 
an age less than 4 years should be used 
to predict severe cases
Ang et al. Singapore 
2009 [49]
Annual incidence rate of HFMD rose from 125.5 in 2001 to 435.9 in 
2007 per 100,000 habitants
HFMD remains a major public health prob‑
lem in Singapore. Must maintain a high 
degree of vigilance, particularly for EV 71
Sarma et al. W. Bengal, 
India 2009 [51]
38 HFMD cases. Children 1–12 years
M:F—21:17. Oral lesions 86.6 %. High incidence of EV71
An alarmingly high prevalence of EV71. 
No significant differences between boys 
and girls
Wu et al. Hangzhou, 
China 2010 [24]
28 HFMD cases
Severe cases <2 years 88.89 %
Severe patients with EV71—92.86 %
Mild patients with EV71—36.51 %
Children under 2 with EV71 are the highest 
risk group for developing the severe form 
of the disease
Suzuki et al. Tokyo, Japan 
2010 [53]
199 HFMD cases. Severe 96. Mild 103
No differences in sex, age, family history. No significant association 
between the center of care and disease presentation
There is no clear association between 
center of care and presentation. More 
studies are needed in this regard
Zeng et al. Shangai, 
China 2012 [26]
28,058 HFMD cases
Neurological disorders, pulmonary edema and hemorrhage 2.6 %
0.04 % deaths
More cases in summer and higher frequency in boys than girls
1–4 years 82.27 %
EV71 positive: 99.17 % severe cases in 2009, 86.31 % in 2010, 100 % 
of patients with neurological affectation, edema, pneumonia and 
hemorrhage
Dominant EV71 circulation led to the 
outbreak of HFMD and the occurrence of 
severe and fatal cases in China
EV71 is associated predominantly with 
severe cases of the disease
Wang et al. Beijing, 
China 2011 [2]
Children 1–3 years OR >2.3
Serious illness OR >1.4
Death OR >2.4
Children OR = 1.56 boys compared to girls
1 day delay in diagnosis associated with severe disease increase  
(40 %) and the probability of death (54 %)
EV71 association with severe disease OR = 16 and death OR = 40, 
regarding CVA16
HFMD is transmissible especially among 
preschoolers. Enterovirus 71 was 
responsible for the most serious cases 
and deaths in China. The mixture of 
asymptomatic infected children in school 
might have contributed to the spread of 
infection. Diagnosis is very important to 
reduce the high mortality rate
Fang et al. Shaoxing, 
China 2014 [43]
19 studies meta‑analysis
Duration of fever ≥3 days [odds ratio (OR) 10.09, 95 % confidence 
interval (CI) 6.22–16.35], body temperature ≥37.5 °C (OR 4.91, 95 % 
CI 1.26–19.18), lethargy (OR 7.75, 95 % CI 3.78–15.89), hyperglycemia 
(OR 2.77, 95 % CI 2.06–3.71), vomiting (OR 8.83, 95 % CI 1.05–74.57), 
increased neutrophil count [weighted mean difference (WMD) 0.61, 
95 % CI 0.52–0.70], enterovirus 71 (EV71) infection (OR 5.13, 95 % CI 
3.11–8.46), young age (WMD—0.44, 95 % CI 0.69–0.19), and home 
care (OR 1.65, 95 % CI 1.26–2.17) were significantly related to the risk 
of severe HFMD
A confirmed diagnosis at first visit to hospital significantly decreased 
the risk of severe HFMD (OR 0.30, 95 % CI 0.09–0.99) not find an 
association between oral rash (OR 1.07, 95 % CI 0.82–1.39), increased 
leukocyte count (WMD 0.51, 95 % CI 0.05–1.06), male sex (OR 
1.06, 95 % CI 0.91–1.24), or living in a rural area (OR 1.39, 95 % CI 
0.95–2.02) and the risk of severe HFMD
Duration of fever ≥3 days, body tempera‑
ture ≥37.5 °C, lethargy, hyperglycemia, 
vomiting, increased neutrophil count, 
EV71 infection, and young age are risk 
factors for severe HFMD. A confirmed 
diagnosis at first visit to hospital can 
significantly decrease the risk of severe 
HFMD
Chen et al. Shangai, 
China [25]
The mean serum VA concentration for all patients was 
0.73 ± 0.26 mmol/L, and 237 (52.7 %) of them presented low con‑
centrations (≥0.7 mmol/L). Both serum concentrations of VA and 
IFN‑a in the patients with complications were significantly lower 
than in patients without complications (P < 0.01)
The decreased concentrations of IFN‑a and EV71‑IgM were positively 
related to lower VA levels (correlation coefficient ¼ 0.58 and 0.41, 
respectively, P < 0.001)
VA status is associated with the antiviral 
immunity and pathogenetic condition 
of HFMD in young children. The children 
with HFMD mostly presented low VA 
concentrations and simultaneously 
had lower serum IFNa levels, decreased 
immune antibody production and more 
severe illness
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development [46], Another study, in 2012 presented the 
first construction and characterization of an infectious 
cDNA clone of CVA16. The availability of this infectious 
clone also improved virological investigations and CVA16 
vaccine development [42]. For 2015, formalin-inactivated 
EV71 (FI-EV71) vaccines have been developed evaluated 
in human clinical trials, and were found to elicit full pro-
tection against EV71, and bivalent FI-EV71/FI-CVA16 
vaccines have been found to elicit strong neutralizing 
antibody responses against both viruses in animal models, 
but nevertheless, there is currently no approved vaccine 
or antiviral substance available for the prevention or treat-
ment of EV71 infection [47, 48].
Prevention
On another note, the HFMD patient is potentially conta-
gious for the duration of the initial symptoms, until the 
vesiculobullous skin lesions disappear. Therefore, patients 
diagnosed with HFMD should be excluded from group 
participation until the fever and skin and mucosal lesions 
have disappeared. Furthermore, the virus is known to be 
shed in the feces for several weeks. It is therefore neces-
sary for patients and family members to know that the 
disease is spread through direct contact with blisters and 
secretions from the nose and throat, as well as through 
hands or utensils contaminated with the feces or secre-
tions of infected people. It is therefore important to 
emphasize washing hands well and to avoid sharing con-
taminated utensils. In the case we presented, up to four 
adults who were in direct contact with the infected child 
suffered from the disease, as in the case described by Shin 
et al. [6]. To prevent the infection from spreading to chil-
dren and vulnerable adults, doctors and dentists should 
be aware that HFMD can also occur in immunocompe-
tent adults [6]. It has also been shown that public health 
measures such as closing schools and hygiene campaigns 
are effective in reducing the incidence rate of HFMD [49].
Due to multiple pathogenic compositions, enteroviral 
recombination, co-infection, spreading and the lack of an 
effective vaccine, outbreaks of the infection can persist 
for a long time. It is therefore vitally important to carry 
out epidemic surveillance of this disease and its compli-
cations, and consequently clinicians should inform health 
authorities to promote citizen participation in dealing 
with large epidemics of HFMD [50, 51].
Our case was resolved spontaneously with sympto-
matic treatment without complications over a period of 
7–10 days, as reflected in other articles [6, 13].
Conclusions
HFMD is a typical childhood illness, but it also occurs 
in adults, which should be kept in mind due to the pos-
sibility of outbreaks, with emphasis on medical history 
and the overall clinical picture, to avoid inadequate treat-
ments with antibiotics.
Dentists have an advantage over other professionals in 
diagnosing the disease, as lesions in the oral cavity are 
the main symptoms that affect the patient, and the den-
tist is therefore frequently one of the first professionals 
to be consulted. Thus, knowledge of the disease and early 
detection prevents the infection from spreading to other 
children and adults. Similarly, dentists have a key role in 
educating patients by recommending good oral hygiene 
to minimize the spread of the disease.
A surveillance system to predict future outbreaks, appro-
priate public health measures and research into vaccine 
development are of vital importance to control HFMD.
Consent
Written informed consent was obtained from the patient 
for publication of this case report and any accompanying 
images.
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